Dr. Truong is the Chair and Associate Professor of Radiation Oncology at BUSM and Chief of Radiation Oncology at Boston Medical Center. She received her medical degree from the University of New South Wales, Sydney Australia and completed her residency in Radiation Oncology at New York University Medical Center, her last year as chief resident. She is board certified in Radiation Oncology by the American Board of Radiology. Her specialties include the treatment of head and neck, skin and central nervous system malignancies, as well as benign diseases, including Airway Amyloidosis. Dr. Truong serves on a number of national committees including the Scientific Committee of the American Society for Therapeutic Radiation Oncology (ASTRO), on the head and neck and skin examination committee of the American Board of Radiology (ABR), and currently serves in NRG Oncology (National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group (GOG)) as the Quality of Life Head and Neck Liaison. She is the Quality of Life Co-Chair on three national head and neck cancer multicenter trials conducted by the NRG Oncology group. She contributes her radiation expertise to the National Cancer Institute’s Adult Oncology Treatment editorial board. She also leads the Cyberknife Radiosurgery program for head and neck malignancies and brain tumors. She is actively involved in promoting clinical research activities at Boston Medical Center, and was awarded funding as Principal Investigator for an American Cancer Society/Boston University Institutional Grant for the investigation of novel function imaging in head and neck cancer using CT perfusion Imaging in Patients with Head and Neck Cancer undergoing Conformal Radiotherapy. Dr. Truong has also contributed to several Boston Medical Center funded research efforts including two U.S. Army Medical Research and Material Command Office Center of Excellence Program Projects and is a project principal investigator of a department of defense funded study investigating the role of stereotactic body radiotherapy for recurrent head and neck cancer.
Head and Neck Cancer
Skin Cancer, Cutaneous T Cell Lymphomas
Central Nervous System Malignancies
Radiotherapy for Airway Amyloidosis
Radiotherapy for Benign Diseases
Stereotactic Radiosurgery and Stereotactic Body Radiotherapy
Intensity Modulated Radiotherapy
Image Guided Radiotherapy
- Chair, Radiation Oncology, Boston University School of Medicine
- Chief, Radiation Oncology, Boston Medical Center
- University of New South Wales, MBBS
- University of New South Wales, BSc
- Published on 10/8/2017
Kamran SC, Qureshi MM, Jalisi S, Salama A, Grillone G, Truong MT. Primary surgery-versus primary radiation-based treatment for locally advanced oropharyngeal cancer. Laryngoscope. 2017 Oct 08. PMID: 28988426.
- Published on 10/1/2017
Patel SA, Qureshi MM, Sahni D, Truong MT. Identifying an Optimal Adjuvant Radiotherapy Dose for Extremity and Trunk Merkel Cell Carcinoma Following Resection: An Analysis of the National Cancer Database. JAMA Dermatol. 2017 Oct 01; 153(10):1007-1014. PMID: 28746702.
- Published on 9/19/2017
Rubin SJ, Kirke DN, Ezzat WH, Truong MT, Salama AR, Jalisi S. Marital status as a predictor of survival in patients with human papilloma virus-positive oropharyngeal cancer. Am J Otolaryngol. 2017 Nov - Dec; 38(6):654-659. PMID: 28947344.
- Published on 8/21/2017
Giacalone NJ, Qureshi MM, Mak KS, Kirke D, Patel SA, Shah BA, Salama AR, Jalisi S, Truong MT. Adjuvant chemoradiation does not improve survival in elderly patients with high-risk resected head and neck cancer. Laryngoscope. 2017 Aug 21. PMID: 28833217.
- Published on 7/3/2017
Rubin SJ, Cohen MB, Kirke DN, Qureshi MM, Truong MT, Jalisi S. Comparison of facility type outcomes for oral cavity cancer: Analysis of the national cancer database. Laryngoscope. 2017 Nov; 127(11):2551-2557. PMID: 28671267.
- Published on 4/24/2017
Mak KS, Agarwal A, Qureshi MM, Truong MT. Hypofractionated short-course radiotherapy in elderly patients with glioblastoma multiforme: an analysis of the National Cancer Database. Cancer Med. 2017 Jun; 6(6):1192-1200. PMID: 28440040.
- Published on 4/12/2017
Shah BA, Qureshi MM, Logue JM, Cooley TP, Zaner KS, Jalisi S, Truong MT. Assessing cumulative acute toxicity of chemoradiotherapy in head and neck cancer with or without induction chemotherapy. Am J Otolaryngol. 2017 Jul - Aug; 38(4):456-461. PMID: 28427799.
- Published on 3/29/2017
Patel SA, Qureshi MM, Mak KS, Sahni D, Giacalone NJ, Ezzat W, Jalisi S, Truong MT. Impact of total radiotherapy dose on survival for head and neck Merkel cell carcinoma after resection. Head Neck. 2017 Jul; 39(7):1371-1377. PMID: 28370725.
- Published on 1/18/2017
Kirke DN, Chitguppi C, Rubin SJ, Truong MT, Jalisi S. Adenoid cystic carcinoma of the base of tongue: A population-based study. Am J Otolaryngol. 2017 May - Jun; 38(3):279-284. PMID: 28173954.
- Published on 8/12/2016
Truong MT, Zhang Q, Rosenthal DI, List M, Axelrod R, Sherman E, Weber R, Nguyen-Tân PF, El-Naggar A, Konski A, Galvin J, Schwartz D, Trotti A, Silverman C, Singh A, Godette K, Bonner JA, Jones CU, Garden AS, Shenouda G, Matthiesen C, Le QT, Bruner D. Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Locally Advanced Head and Neck Carcinoma: NRG Oncology Radiation Therapy Oncology Group 0522. Int J Radiat Oncol Biol Phys. 2017 Mar 15; 97(4):687-699. PMID: 27727066.
View 40 more publications: View full profile at BUMC